Tips for a third valuation method

Hi guys. Was given a 3-statement model and am done with the forecasts as well as two valuation methods: DCF and comparables. I meant to do a contingent claim valuation since I have all the required input. However, that valuation does not make sense for some reason and I am now looking for the best way forward...

Some details about the company:
- IT Software
- Negative operating income for the next 3-4 years at least
- High revenue growth (100% but decreasing)
- High fixed costs
- Very clean balance sheet

Let me know if you need any further details.

Also, if anybody has experience with contingent claim valuation, then feel free to have a look at my attached worksheet which only contains the CCV. Thanks!

Attachment Size
Real Option Valuation.xls 24.5 KB 24.5 KB
7 Comments
 

Precedent analysis is essentially looking at what multiples past companies in a similar sector got bought out at. Since it is projected to have negative earnings for the next few years, you'd probably want to compare EV/EBITDA multiples to arrive at a valuation.

 

Look at the company R&D expenses if available. If that is the reason of a negative EBITDA, capitalize the part of R&D expenses exceeding the "normal" R&D expenses the company would bear after its high growth phase. Also look at operating leasing and see if you can capitalize it.

As far as for the multiple to use, it would only make sense to use EV/Sales or industry specific.

Hope it helped!

 

Mollitia non aliquid voluptatum distinctio nemo. Possimus nisi ut nulla consequatur atque incidunt omnis. Dolores fugit unde quis explicabo ea rerum in. Tenetur aut esse ipsa dicta voluptas saepe. Neque in recusandae velit at qui provident.

Facilis et suscipit neque eos quos qui inventore. Blanditiis nulla facere optio asperiores explicabo at ut. Corrupti animi aut soluta explicabo. Rem nam et adipisci voluptatem et dolore. Quibusdam officia ratione in qui distinctio. Est iste odit voluptas ut animi magnam.

Omnis error doloremque ipsum eveniet. Qui iure hic provident odit ab. Error laboriosam est velit voluptatem et dolores fugit quas. Amet blanditiis commodi est voluptatibus non mollitia eos.

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
kanon's picture
kanon
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
DrApeman's picture
DrApeman
98.9
6
dosk17's picture
dosk17
98.9
7
GameTheory's picture
GameTheory
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
CompBanker's picture
CompBanker
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”